AGO2 and neoplasm: The selective release of miRNAs may occur through several mechanisms, including exosomal transport, where miRNAs are packaged into vesicles and secreted from the cell; active export mediated by RNA-binding proteins such as Argonaute 2 (Ago2); or passive release from tumor cells undergoing stress, damage, or cell death (29, 30).